Contingency Management for Persons With Severe Mental Illness

Substance Abuse Clinical Trial

Official title:

Contingency Management for Persons With Severe Mental Illness

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01478815
• Other study ID #: 12-070-3
• Secondary ID: P30DA023918
• Status: Completed
• Phase: N/A
• Start date: December 2011
• Est. completion date: August 2012

Study information

• Verified date: April 2019
• Source: UConn Health
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Contingency management is efficacious for treating cocaine abuse, but contingency management interventions have rarely been applied to patients with severe and persistent mental health problems. This pilot project will estimate effect sizes of contingency management for reducing cocaine use in patients receiving psychiatric care at a large community based mental health program. In total, 30 cocaine abusing patients will be randomized to one of two 8-week treatment conditions: standard care or standard care with contingency management. Patients in both conditions will provide breath and urine samples for toxicology testing twice per week. In the contingency management condition, patients will receive the opportunity to win prizes for submitting cocaine negative urine samples. The investigators expect that patients receiving contingency management will evidence reductions in cocaine use and may show improvements in psychiatric symptoms and psychosocial functioning relative to patients in standard care. Effect size estimates obtained from this study will be used to guide larger scale and longer duration evaluations of contingency management for dually diagnosed patients.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 19
• Est. completion date: August 2012
• Est. primary completion date: August 2012
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• age 18 years or older

• meet DSM-IV criteria for cocaine abuse or dependence

• English speaking

• pass a brief quiz regarding study procedures to ensure understanding of the informed consent process.

Exclusion Criteria:

• dementia

• in recovery from pathological gambling

Related Conditions & MeSH terms

• Mental Disorders
• Substance Abuse
• Substance-Related Disorders

Intervention

Behavioral:
• contingency management
Participants will receive the opportunity to win prizes for submitting cocaine negative urine samples.

Other:
• Standard Care
Standard Care

Locations

Country	Name	City	State
United States	Community Mental Health Affiliates, Inc.	New Britain	Connecticut

Sponsors (2)

Lead Sponsor	Collaborator
UConn Health	National Institute on Drug Abuse (NIDA)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	longest continuous period of cocaine abstinence		Week 8
Secondary	other drug use and psychosocial problems		Week 8